IL33 and exocrine pancreatic carcinoma: Supporting these data, studies involving HNSCC, pancreatic carcinoma and colon carcinoma cell lines suggest that IL-33 is an autocrine/paracrine mediator of carcinoma cell invasiveness and metastasis [22–25].